Background/Aims: To date, the best therapeutic modality for gastric adenoma, especially low-grade adenoma, has not been established. The aim of this study was to assess the usefulness of argon plasma coagulation (APC) in treating gastric adenoma compared with endoscopic submucosal dissection (ESD). Methods: We included 210 patients with gastric adenoma, who underwent treatment with either APC (97 patients) or ESD (113 patients). The clinical and pathologic characteristics, mean duration of hospital stay, complications, and recurrence rates between the two groups were compared. Results: The mean adenoma size was 0.9 cm and 1.1 cm in the APC group and ESD group, respectively (p<0.001). The mean duration of hospital stay was significantly shorter in the APC group than in the ESD group (1.6 days vs. 5.8 days, p<0.001). Complications did not occur in the APC group. However, one case of perforation (0.9%) and 6 cases of bleeding (5.3%) occurred in the ESD group. The recurrence rates were 15.3% (15/97 patients) in the APC group and 3.5% (4/113 patients) in the ESD group (p=0.003). The proportion of hospitalization was less in the APC group (43.3%, 42/97) than in the ESD group (100.0%, 113/113) (p<0.001). Medical expense was less in the APC group (377,172 won) than in the ESD group (1,430,610 won) (p<0.001). Conclusions: The findings of this study suggest that APC is a safe treatment method for gastric adenoma without serious complications. However, regular endoscopic follow-up is necessary to detect any residual or recurrent lesions due to the relatively high rate of local recurrence after APC. (Korean J Gastroenterol 2017;69:283-290) 
INTRODUCTION
Gastric adenoma is usually classified using a two-grade system: low-grade dysplasia (LGD) and high-grade dysplasia (HGD). [1] [2] [3] The clinical importance of gastric adenoma has been emphasized due to its close association with the risk of developing gastric cancer. 2 Gastric adenoma is generally accepted as a precancerous lesion. In most instances, it remains stable or regressed, although it can progress at a slow rate. 1 Thus, it can be removed by an endoscopic resection or surgical resection, when possible. 4 In particular, endoscopic submucosal dissection (ESD) is not limited by resection size
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The Korean Journal of Gastroenterology and is expected to replace surgical resection. However, it is still associated with a higher incidence of complications than standard endoscopic mucosal resection (EMR) procedures, requiring a high level of endoscopic skill. 5, 6 Considering its limitation, new feasible treatment methods are required for gastric adenoma. Argon plasma coagulation (APC) is a method of contact-free electrocoagulation, whereby energy is transmitted to the tissue through an ionized argon gas. 7, 8 APC has widely been used to treat many gastrointestinal diseases, including bleeding peptic ulcer, watermelon stomach, hemorrhagic proctitis, and esophageal varices. 9, 10 Recently, its application has been broadened into the field of treatment for gastric adenoma. 11 The purpose of this study was to investigate the clinical efficacy and to assess the usefulness of APC in treating gastric adenoma compared with ESD.
SUBJECTS AND METHODS

Patients
We retrospectively reviewed patients with gastric adenoma, who underwent treatment endoscopically at Inje University Ilsan Paik Hospital, between January 2006 and June 2013.
All lesions had been identified with endoscopic examination at our institution. Before APC or ESD treatment, endoscopic examination was performed, and at least three biopsy specimens were taken from the lesions. Treatment methods, classified as either APC or ESD, were chosen at the discretion of each oeprating physician. Three endoscopists performed both diagnostic and therapeutic procedures. Each endoscopic report was reviewed to identify the lesion size and gross appearance. After discharge, follow-up endoscopic examinations with biopsy were performed at 3, 6, and 12 months post-operation, then every 12 months thereafter.
Patients who were previously treated at another hospital or those who were lost to follow-up were excluded from the final analysis: Five patients had undergone prior treatment at another hospital, and nine had failed to successfully be followed-up for more than three months. The largest lesion was selected in the analysis if a patient had multiple adenoma.
Finally, a total of 210 patients with gastric adenomas were included for analysis. Patients were treated with either APC (97 patients) or ESD (113 patients). Perforation was classified as macro-and microperforation.
Endoscopic procedures and complications
Macroperforation was readily recognized endoscopically, while microperforation was detected by the presence of free air on plain radiographs taken after the procedure.
Clinical analysis
Clinical, pathologic data, treatment modalities, and outcomes were collected from the medical records of all patients.
Clinical data included sex, age, tumor site, tumor size, and macroscopic morphology. The types of macroscopic morphology were classified as elevated, flat, or depressed, as proposed by the Paris classification. 12 We compared the clinical and pathologic characteristics, admission rates, mean duration of hospital stay, complications, and recurrence rates between the two groups. The study protocol was approved by the institutional review board of Ilsan Paik Hospital, Inje University College of Medicine, Goyang, Korea.
Statistical analysis
To analyze the baseline characteristics, Pearson's chi-squared and Fisher's exact tests were used for categorical variables and t-test was used for continuous variables. Continuous variables are shown as the mean and standard deviation.
Statistical significance was set at a p-value of less than 0.05. 
RESULTS
Patients and baseline clinical characteristics
A total of 210 patients were eligible for this study: 97 patients were treated with APC and 113 patients with ESD. The baseline characteristics of the 210 patients are summarized in Table 1 The proportion of high-grade dysplasia was 2.1% and 23.9% in the APC group and ESD group, respectively (p<0.001).
There were more adenomas with elevated morphology in the ESD group than in the APC group (79.6% vs. 60.8% p=0.01).
Local recurrence, complication, admission, and cost comparison between the APC and ESD group
Following the procedures, 97 patients in the APC group and 113 patients in the ESD group had regularly follow-up visits.
The median follow-up duration for the APC and ESD groups was 6.0 (range 3-36) months and 12.0 (range 3-48) months, respectively. En bloc resection was attempted in all ESD cases, with a complete resection rate of 89.4 % (101 of 113). In 11 patients, the lateral margin of the resected specimen was histologically positive. The residual tumor was treated by APC, and there was no recurrence during the follow-up period after APC. In one patient, the vertical margin of the resected specimen was histologically determined to be early gastric cancer, and surgery was carried out. There was no recurrence during the follow-up period after surgery. Recurrence rates were higher in the APC group than in the ESD group (15.3%
vs. 3.5%, p=0.003) ( Table 2) .
Complications did not occur in the APC group. However, one case of microperforation (0.9%) and six cases of bleed-
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Subgroup analysis among APC cases
The subgroup analysis by admission status was performed among patients who were treated by APC. Table 3 shows clinical characteristics between the two groups stratified by admission status. The subgroup analysis included 97 patients.
Among those treated by APC, 55 patients (56.7%) were outpatients and 42 patients (43.3%) were inpatient. There were no significant differences with respect to the characteristics between two groups, except vertical location. Table 4 shows the treatment results between the two groups. There was no significant difference between the two groups in the recurrence rate (APC-outpatient 16.4% vs. Values are presented as n (%) or mean±standard deviation unless otherwise indicated. APC, argon plasma coagulation. 1,079,698 won, p<0.001).
Clinical characteristics, endoscopic findings, and treatment sequence of patients with local recurrence for APC
The local recurrence of the APC group was frequently observed as the elevated type (14 of 15) (Table 5) . Otherwise, of all the flat lesions, no recurrence was observed (0 of 33).
Four patients with adenomas ≥2.0 cm were treated with APC, and 2 of them experienced recurrence. There was a significant difference in the recurrence rate between adenomas ≥2 cm (50%, 2/4) and adenomas <2 cm (13.9%, 13/93) (p=0.047). However, there was no statistical difference in the recurrence rate between adenomas <1 cm (10.7%, 6/56) and adenomas 1-2 cm (18.9%, 7/37) (p=0.253). There was no difference in the recurrence rate according to vertical location (p=0.504). All patients (except one, who was lost to follow-up) were treated using APC or ESD or surgery. Six patients were treated by repeat APC. Seven patients were retreated by ESD. One patient was treated by surgery because the pathology was noted as early gastric cancer type IIa. There was no recurrence in six patients after repeat APC (Table 5) .
DISCUSSION
Gastric adenoma is generally accepted as a precancerous lesion, and neoplastic risk differs by the type of dysplasia.
1
LGD is known to regress in 38-49% of patients, while persist
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The Korean Journal of Gastroenterology in 19-28%, and progress to HGD in 1-15%. HGD is known to regress in 5% of patients, persist in 14%, and progress in 81-85%. 2 Although most cases of LGD are believed to regress or persist, some cases have been reported to progress to HGD or carcinoma after the median follow-up period, ranging from 34.5 to 41.5 months in one study. 13 Based on these characteristics, APC treatment has many merits over endoscopic resection and frequent endoscopic follow-up, including short procedure time, low risk of bleeding and perforation, low procedure cost, and no requirement of hospitalization. 11 Therefore, APC can be regarded as a reasonable treatment method for gastric adenomas with LGD.
Previous reports have indicated a local recurrence rate of 4-10% after APC in cases of early gastric cancer or gastric adenoma. 15, 16, 20, 21 However, to the best of our knowledge, an analysis of risk factors for local recurrence has not yet been performed. Our present study showed a high rate of local recurrence (15.3%) compared with other studies. The local recurrence of treated adenomas using APC in our study was frequently observed as the elevated type (14 of 15). Otherwise, no recurrence was observed in all the flat lesions (0 of 33).
Moreover, the local recurrence of treated adenomas using APC was frequently observed to be large. There was no statistical significance; however, adenomas with a size of 1-2 cm tended to have a higher recurrence rate than those <1 cm (18.9% vs. 10.7%, p=0.253). Four patients with adenomas ≥2.0 cm were treated with APC, and two of them showed recurrence. This was potentially due to the insufficient coagulation depth that may occur from using the APC therapy, since the tumor volume is greater in the elevated lesions than in the flat type lesions of the same size. Therefore, APC may be a satisfactory and effective modality for flat lesions with a relatively small size. This finding has also been reported in other studies.
11,21
Other studies observed that all recurrent lesions following APC were superficial elevated type. 11, 21 Moreover, a recent study showed that non-lifting after submucosal saline injection and a lower power setting of 40 W are both risk factors for local recurrence after APC, with a lower reported rate of local recurrence in lifting and 60 W or 80 W groups than in non-lifting and 40 W groups. 22 In that study, the authors concluded that a higher power setting of 60 W or 80 W may be safe and effective for treating gastric neoplasms by APC. 22 To reduce the recurrence rate, additional sessions of APC and changing the power setting in accordance with the tumor volume may be necessary. In addition, the depth of affecting tissue will likely increase as the APC application time over the same area increases. Therefore, the physician should treat with an activation time that corresponds with the desired effect.
In this study, among the 15 patients with recurrent lesions treated with an APC procedure, 6 patients were treated by secondary APC. There was no recurrence in all six repeated APC cases. Thus, even if recurrence is more frequent following APC than ESD, repeated APC treatments can be a good option for local recurrence. Certainly, regular follow-up is needed after APC to monitor for any local recurrence.
With respect to complications, perforation occurred in one patient who underwent ESD. However, there were no perforations in the APC group. APC-related perforation is very rare, accounting for about 0.3% in one study. 23 This is much lower than with ESD (1-6%). [24] [25] [26] Moreover, it is noteworthy that there was no significant difference regarding the recurrence rate in the APC groups, on an outpatient and admission basis. In addition, no complication was observed in both groups. This suggests that APC is an effective and safe treatment modality for gastric adenoma on an outpatient basis. The APC group on an outpatient basis was shown to be five times more economical than ESD.
Actually, some patients preferred APC to ESD due to hospital admission issues or economic considerations. Endoscopic resection remains technically difficult and cannot be performed in some cases due to high risk of bleeding or perforation as well as due to non-lifting after submucosal saline injection. APC may be one alternative treatment that is less invasive for patients with high risk of ESD-related complications.
Moreover, APC does not differ according to endoscopic experience. It shows equal therapeutic outcomes between experienced and non-experienced endoscopists. Therefore, non-experienced endoscopists could treat small gastric adenomas that do not require a long training period, such as that required for ESD. 11, 21 There are several limitations to this study. First, this was a single-center study with a limited number of patients. Second, the retrospective nature of this study may have resulted in a selection bias, which may have likely played a role in the choice of treatment modality (APC vs. ESD). In this study, there were more adenomas with larger size and with elevated type in the ESD group than in the APC group. There were more lesions on the lower-third location in the ESD group. Moreover, the proportion of high-grade dysplasia was higher in the ESD group than in the APC group. In addition, short follow-up duration may be another limitation. Further randomized prospective studies are necessary to confirm that APC is a more effective and reasonable treatment for gastric adenomas compared with ESD.
In conclusion, this study demonstrated that gastric adenoma can be safely treated by APC without serious complications. Due to its association with minimal hospital admission, low medical cost, and favorable outcomes, as well as very low complication rates, APC may be a good treatment option, especially for relatively small, flat adenomas. However, regular endoscopic follow-up is necessary to detect any residual or recurrent lesions, as it has been shown to have a relatively higher rate of local recurrence after APC.
